Presidential Lecture
Symposium Upper GI-1
Pathways to Gastric Neoplasia: Integrating Mutational, Epigenetic, and Spatial Dynamics
Symposium GI Oncology-1
Advances in Immunotherapy for Gastrointestinal Cancers
Postgraduate Course- Pancreatobiliary
Gallstone Disease in Clinical Practice
Symposium KSG-1: BigData
Big Data-Driven Innovation in Gastroenterology
Symposium Upper GI-2
Endoscopic Management of Upper GI Bleeding: From Basics to AI-Guided Precision
Symposium Pancreatobiliary-1
Navigating Pancreatic Cystic Neoplasms: From Global Consensus to Precision Management
Postgraduate Course-Lower GI
Current Practices to Emerging Therapies in Lower Gastrointestinal Diseases
Symposium Liver-1
Advances in Systemic Therapy for HCC: From Intermediate to Advanced Stages
MDT Session-1
GLP-1 Receptor Agonists in Gastroenterology and Hepatology
Postgraduate Course-Upper GI
Recent Advances and Guideline Updates in Gastric Diseases
KSG-Korean American Gastroenterology Network
Evolving Concepts and Innovations in Pancreatobiliary Endoscopy
Omics Joint Symposium I
Symposium Lower GI-1
Emerging Issues in IBD
Symposium FGID/Motility-1
Esophageal Motility Disorders 2026: From Diagnosis to Clinical Practice
Postgraduate Course-GI Oncology
Check List Before Starting Chemotherapy
Symposium KSG-2: Pediatric/Surgery
EEN and Surgical Core for GI Doctor
Omics Joint Symposium II
Lawrence S. Kim, MD, AGAF, is the 120th President of the American Gastroenterological
Association (AGA) Institute for the 2025–2026 term. He officially began his presidency on May 28,
2025, succeeding Dr. Maria T. Abreu. As president, Dr. Kim has focused on several core
initiatives: 1) Inclusivity: Promoting a "message of inclusivity" for all gastroenterologists, regardless
of work setting (academic vs. private practice), 2) Independent Practice Advocacy: Supporting the
viability of independent GI practices and advocating for issues like Medicare reimbursement and
prior authorization reform. 3) Innovation: Strengthening the AGA's GI Opportunity Fund and venture
capital initiatives to invest in new technologies.
It is highly exceptional for a Korean-American physician to serve as President of the AGA, and
President Kim’s lecture will undoubtedly resonate deeply with our Korean gastroenterologists and
the broader audience. His talk, drawing on his career-long perspective on the evolution of
colorectal cancer screening and how our field continues to adapt, will deliver an inspiring and
timely message in Korea.
This lecture will provide an inspiring and timely message, offering valuable insights for
gastroenterologists, clinicians, and researchers seeking to stay at the forefront of colorectal
cancer prevention and care. Don’t miss this unique opportunity to learn from a global leader in
gastroenterology and colorectal cancer screening.
Yong Chan Lee, the chairman of the Korean Society of Gastroenterology (KSG), is a distinguished
gastroenterologist and academic leader in Korea, with extensive contributions to clinical practice,
research, and scholarly publishing in gastroenterology. He currently serves as Chairman of the
Korean Society of Gastroenterology and President of the Korean Society of Upper Gastrointestinal
Disorders and Helicobacter Research. Professor Lee also plays a key role in academic publishing
as Editor-in-Chief of Gut and Liver (SCIE-indexed journal) and as an editorial board member of
the Journal of Gastroenterology and Hepatology (SCI). In addition, he serves as Editorial Director
of the Korean Society of Neurogastroenterology and Motility, contributing to the advancement of
research and education in gastrointestinal motility disorders. Through his leadership in professional
societies and international journals, Professor Lee has significantly influenced the development of
gastroenterology research and clinical standards both in Korea and globally.
In this lecture, Professor Lee will explore the complex interplay between chronic inflammation, the
gastric microbiome, and gastric carcinogenesis, offering cutting-edge perspectives on disease
mechanisms and future clinical implications. Drawing on his extensive research experience and
leadership in international gastroenterology, this session promises to deliver valuable insights for
clinicians and researchers alike.
Do not miss this opportunity to gain a deeper understanding of the evolving role of the microbiome
in gastric cancer and its impact on prevention, diagnosis, and therapeutic strategies.